SCS Capital Management
NVS icon

SCS Capital Management’s Novartis NVS Stock Holding History

SCS Capital Management’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,114
Closed -$429K – 492
2025
Q4 		$429K Buy
3,114
+88
+3% +$11.5K ﹤0.01% 391
2025
Q3 		$388K Sell
3,026
-1,725
-36% -$210K ﹤0.01% 415
2025
Q2 		$575K Sell
4,751
-459
-9% -$51.7K 0.01% 360
2025
Q1 		$586K Buy
+5,210
New +$555K 0.01% 322

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCS Capital Management's NVS Position: Q1 2026 in Review

SCS Capital Management sold out of Novartis (NVS) in Q1 2026, closing a stake of 3,114 shares — an estimated $429K sold.

SCS Capital Management first reported a position in NVS in Q1 2025 and held it in 4 quarters. The position peaked at $586K in Q1 2025. 1,604 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • SCS Capital Management reported no remaining Novartis position as of Q1 2026 after selling out during the quarter.
  • SCS Capital Management sold 3,114 Novartis shares in Q1 2026, an estimated $429K.
  • SCS Capital Management first reported a position in Novartis in Q1 2025 and held it in 4 quarters.
  • SCS Capital Management's Novartis position peaked at $586K in Q1 2025.
  • 1,604 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on SCS Capital Management's 13F filing for Q1 2026, filed 11 May 2026.